These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9364164)

  • 21. Postmenopausal osteoporosis: Assessment and management.
    Rizzoli R
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):739-757. PubMed ID: 30449552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient handout. What midlife women should know about osteoporosis risk and treatments.
    Menopause; 2014 Mar; 21(3):e2. PubMed ID: 24518156
    [No Abstract]   [Full Text] [Related]  

  • 23. Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures.
    Guyatt GH; Cranney A; Griffith L; Walter S; Krolicki N; Favus M; Rosen C
    Endocrinol Metab Clin North Am; 2002 Sep; 31(3):659-79, xii. PubMed ID: 12227126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating recruitment strategies for AUSPICE, a large Australian community-based randomised controlled trial.
    Peel R; Ren S; Hure A; Evans TJ; D'Este CA; Abhayaratna WP; Tonkin AM; Hopper I; Thrift AG; Levi CR; Sturm J; Durrheim D; Hung J; Briffa TG; Chew DP; Anderson P; Moon L; McEvoy M; Hansbro PM; Newby DA; Attia JR
    Med J Aust; 2019 May; 210(9):409-415. PubMed ID: 30907001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newspaper advertising could distort research results.
    Hébert R
    Nicotine Tob Res; 2000 Nov; 2(4):317-8. PubMed ID: 11197310
    [No Abstract]   [Full Text] [Related]  

  • 26. Recruiting Dementia Caregivers Into Clinical Trials: Lessons Learnt From the Australian TRANSCENDENT Trial.
    Leach MJ; Ziaian T; Francis A; Agnew T
    Alzheimer Dis Assoc Disord; 2016; 30(4):338-344. PubMed ID: 27227995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Postmenopausal osteoporosis: its epidemiology, prevention and treatment].
    Nagant de Deuxchaisnes C
    Bull Mem Acad R Med Belg; 1989; 144(5-7):295-308; discussion 308-12. PubMed ID: 2695199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What are the new French recommendations for the treatment of postmenopausal osteoporosis?].
    Blain H
    Rev Med Interne; 2019 May; 40(5):275-277. PubMed ID: 29891260
    [No Abstract]   [Full Text] [Related]  

  • 29. The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.
    ; Ip TP; Cheung SK; Cheung TC; Choi TC; Chow SL; Ho YY; Kan SY; Kung WC; Lee KK; Leung KL; Leung YY; Lo ST; Sy CT; Wong YW;
    Hong Kong Med J; 2013 Apr; 19 Suppl 2():1-40. PubMed ID: 23535738
    [No Abstract]   [Full Text] [Related]  

  • 30. Consensus summary on the diagnosis and treatment of osteoporosis.
    Andersson GB; Bostrom MP; Eyre DR; Glaser DL; Hu SS; Lane JM; Melton LJ; Myers ER; Seeger LL; Weinstein JN
    Spine (Phila Pa 1976); 1997 Dec; 22(24 Suppl):63S-65S. PubMed ID: 9431647
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evidence-based medicine and drug selection of osleoporosis prevention after menopause].
    Xu L
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):265-6. PubMed ID: 15059503
    [No Abstract]   [Full Text] [Related]  

  • 32. Improving recruitment to primary care trials: some lessons from the use of modern marketing techniques.
    Colwell B; Mathers N; Ng CJ; Bradley A
    Br J Gen Pract; 2012 Sep; 62(602):496-8. PubMed ID: 22947576
    [No Abstract]   [Full Text] [Related]  

  • 33. Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?
    Hathirat S; Evans MF
    Can Fam Physician; 2001 Oct; 47():1982-4. PubMed ID: 11723592
    [No Abstract]   [Full Text] [Related]  

  • 34. The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy.
    Rosen CJ; Kessenich CR
    Endocrinol Metab Clin North Am; 1997 Jun; 26(2):295-311. PubMed ID: 9193885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of recruitment to a smartphone-delivered nutrition intervention in New Zealand: analysis of a randomised controlled trial.
    Volkova E; Michie J; Corrigan C; Sundborn G; Eyles H; Jiang Y; Mhurchu CN
    BMJ Open; 2017 Jul; 7(6):e016198. PubMed ID: 28674144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise for preventing and treating osteoporosis in postmenopausal women.
    Howe TE; Shea B; Dawson LJ; Downie F; Murray A; Ross C; Harbour RT; Caldwell LM; Creed G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD000333. PubMed ID: 21735380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis.
    Bond K
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1991; 2(4):497-508. PubMed ID: 1772735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of whole-body vibration therapy on bone metabolism, motor function, and anthropometric parameters in women with postmenopausal osteoporosis.
    Luo X; Zhang J; Zhang C; He C; Wang P
    Disabil Rehabil; 2017 Nov; 39(22):2315-2323. PubMed ID: 27718643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cost-Time Index: a new method for measuring the efficiencies of recruitment-resources in clinical trials.
    Ota KS; Friedman L; Ashford JW; Hernandez B; Penner AL; Stepp AM; Raam R; Yesavage JA
    Contemp Clin Trials; 2006 Dec; 27(6):494-7. PubMed ID: 16820328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.